The global peptide therapeutics market size has been estimated at USD 52.59 billion in 2025 and is expected to reach around ...

the administration of ampicillin and gentamicin resulted in an increased rate of blanching, catheter clot, and pseudomembranous enterocolitis. The frequency of complications when total parenteral ...

Fresenius Kabi, an operating company of Fresenius, announced today it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the treatment of symptomatic Paget's disease ...

Eli Lilly and Company (NYSE: LLY) today announced that the National Medical Products Administration (NMPA ... will extend the company's global parenteral (injectable) product manufacturing ...

Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...

Pharmaceutical Lipids Market to Reach USD 9,036.5 Million by 2035, Rising demand for lipid-based drug delivery fuels market growth, enhancing solubil ...

Dry Eye Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future grow ...

Canada NewsWire MONTREAL, Feb. 13, 2025 MONTREAL, Feb. 13, 2025 /CNW/ - Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® ...

Consider holding tube feeding for at least one to two hours before and after medication administration if drug absorption may be affected.